Submissions for variant NM_172056.2(KCNH2):c.2192A>C (p.His731Pro) (rs794728385)

Total submissions: 1

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000181841	SCV000234144	likely pathogenic	not provided	2014-01-31	criteria provided, single submitter	clinical testing	Tp.His731Pro (CAC>CCC): c.2192 A>C in exon 9 of the KCNH2 (HERG) gene (NM_000238.2)The H731P variant in the KCNH2 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. The H731P variant is a non-conservative amino acid substitution as these residues differ in polarity, charge, size and/or other properties and is more likely to impact secondary structure. The H731 residue is conserved across species. In silico analysis predicts H731P is probably damaging to the protein structure/function. Mutations in nearby residues (P721L, I728F, S735L) have been reported in association with LQTS, further supporting the functional importance of this region of the protein. Furthermore, the H731P variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.In summary, while H731P is a good candidate for a disease-causing mutation, with the clinical and molecular information available at this time we cannot unequivocally determine the clinical significance of this variant. The variant is found in LQT panel(s).